Hospitalized patients with type 2 diabetes, especially those who have a prolonged length of stay, experienced better glycemic control with glulisine as compared with regular insulin, according to ...

Patients and health care professionals can expect a shortage of insulin glulisine prefilled pens, including Apidra Optiset and Apidra SoloStar, and reusable cartridges, including Apidra ClikStar ...

Find out how to take Insulin Glulisine(drug) and its dose. Describes the best time to take the drug and precautions if any that should be followed.

Sanofi-aventis has received approval for Apidra (insulinglulisine [rDNA origin] injection) to improve glycemic control in children agedfour years and older with diabetes mellitus. The clearance ...

Insulin Glulisine Medication Information. Learn everything you need to know about Insulin Glulisine-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it.

April 22, 2004 — The U.S. Food and Drug Administration (FDA) has approved insulin glulisine injection for diabetes, triamcinolone acetonide nasal aerosol for allergic rhinitis, abacavir sulfate ...

French drugmaker Sanofi-Aventis has launched its rapid-acting insulin Apidra (insulin glulisine) in the USA for people with diabetes. The new product’s major selling point is its flexibility: it can ...

The prospective, multicenter, randomized trial included 130 insulin-naive patients with type 2 diabetes who were randomly allocated to receive a basal-bolus regimen of glargine and glulisine (n ...

Insulin glulisine (brand name Apidra) was added as an EDS medication in April. Advertisement 2. Story continues below. This advertisement has not loaded yet, but your article continues below.